ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nebraska » Pulmonary Disease

Top Pulmonary Disease Prescribers in Nebraska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
J. SHEHAN M.D.

Pulmonary Disease

4,283

$598K

452
377 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 55%

$140
Average prescription price

Avg: $228

SEAN BARRY M.D.

Pulmonary Disease

3,602

$378K

230
156 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 55%

$105
Average prescription price

Avg: $228

SALAM SALMAN M.D.

Pulmonary Disease

2,426

$291K

352
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 55%

$120
Average prescription price

Avg: $228

WILLIAM JOHNSON M.D.

Pulmonary Disease

2,112

$725K

303
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 55%

$343
Average prescription price

Avg: $228

JOHN RUDERSDORF M.D.

Pulmonary Disease

2,093

$353K

287
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 55%

$168
Average prescription price

Avg: $228

KEVIN REICHMUTH M.D.

Pulmonary Disease

1,950

$217K

214
171 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 55%

$111
Average prescription price

Avg: $228

PATRICK MEYERS M.D.

Pulmonary Disease

1,947

$202K

322
270 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 55%

$104
Average prescription price

Avg: $228

DAVID CANTRAL M.D.

Pulmonary Disease

1,946

$393K

243
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 55%

$202
Average prescription price

Avg: $228

GEORGE THOMMI M.D.

Pulmonary Disease

1,919

$234K

310
259 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 55%

$122
Average prescription price

Avg: $228

MATTHEW MCLEAY M.D.

Pulmonary Disease

1,856

$214K

257
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 55%

$116
Average prescription price

Avg: $228

ANUP CHAKRABORTY M.D.

Pulmonary Disease

1,766

$300K

331
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 55%

$170
Average prescription price

Avg: $228

WAJAHAT KHALIL M.D.

Pulmonary Disease

1,763

$358K

276
218 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 55%

$203
Average prescription price

Avg: $228

ELLEN MILLER M.D.

Pulmonary Disease

1,717

$258K

220
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 55%

$150
Average prescription price

Avg: $228

GUILLERMO HUERTA MD

Pulmonary Disease

1,677

$420K

207
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 55%

$250
Average prescription price

Avg: $228

JEFFREY JARRETT MD

Pulmonary Disease

1,399

$531K

225
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 55%

$380
Average prescription price

Avg: $228

JOHN TRAPP M.D.

Pulmonary Disease

1,165

$752K

210
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 55%

$645
Average prescription price

Avg: $228

LISA MANSUR MD

Pulmonary Disease

1,110

$103K

153
124 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 55%

$93
Average prescription price

Avg: $228

DOUGLAS FIEDLER MD

Pulmonary Disease

1,106

$218K

209
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 55%

$197
Average prescription price

Avg: $228

PETER MURPHY MD

Pulmonary Disease

986

$491K

27
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 55%

$498
Average prescription price

Avg: $228

FRANK MEZZACAPPA MD

Pulmonary Disease

912

$154K

145
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 55%

$169
Average prescription price

Avg: $228

TIMOTHY LIESKE M.D.

Pulmonary Disease

833

$170K

144
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 55%

$204
Average prescription price

Avg: $228

LOUIS VIOLI MD

Pulmonary Disease

827

$116K

148
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 55%

$140
Average prescription price

Avg: $228

BRYAN KRAJICEK M.D.

Pulmonary Disease

811

$133K

150
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 55%

$164
Average prescription price

Avg: $228

LON KEIM M.D.

Pulmonary Disease

713

$285K

103
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 55%

$399
Average prescription price

Avg: $228

AUSTIN THOMPSON MD

Pulmonary Disease

712

$1.23M

74
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 55%

$1733
Average prescription price

Avg: $228

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank